Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma
Recruiting
Observational Study
Fractures, Bone
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Artoss Inc. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This multicenter prospective patient registry was developed with the aim of documenting how orthopedic surgeons are utilizing the NanoBone products in acute trauma cases along with relevant patient outcomes. These outcomes include radiographic measures such as fracture healing, instrumentation integrity, and clinical outcomes (symptom and function improvement) based on investigator and patient-bas…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Subjects at least 18 years old at the time of injury
2. Acute fractures, resulting from blunt or penetrating trauma
* In the extremities or pelvis
* Requiring surgery
* Treated emergently, delayed or staged up to 4 weeks from the date of injury
* Where bone graft…
Contacts